RxDoctor Payments Data

Madhur Garg, MD

Radiation Oncology · Bronx, NYNPI 1215018643

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $3,490 of the $4,491 with a category attached, or 77.7%. Elekta, Inc. accounts for 68.0% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $3,228 and has fallen 78.5% since, to $694 in 2025.

$4,491in general payments, 2019–2025

Across 12 payments — averaging $374.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Elekta, Inc.$3K
  • Reflexion Medical, Inc.$583
  • Siemens Medical Solutions USA, Inc.$234
  • Varian Medical Systems, Inc.$186
  • Accuray Incorporated$141
  • Palette Life Sciences, Inc.$136
  • plus $159 from 2 others
$286,652in research payments, 2019–2025

Across 9 payments — averaging $31,850 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$181K
  • Varian Medical Systems, Inc.$90K
  • Siemens Medical Solutions USA, Inc.$16K

What the payments were for

  • Travel & lodging$3,49078%
  • Food & beverage$1,00122%

General payments by program year

19
21
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,491 in reported general payments places this provider in the 85th percentile of 397 radiation oncology providers in New York.

See all radiation oncology providers in New York

Medicare billing

Part B allowed, 2024
$50,008
Medicare patients
116
Services billed
402

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl11$62

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Bronx

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →